000 01228 a2200373 4500
005 20250513040426.0
264 0 _c19930916
008 199309s 0 0 rus d
022 _a0869-6047
040 _aNLM
_beng
_cNLM
100 1 _aZolin, V V
245 0 0 _a[Methodological approaches to creating a liposomal form of human recombinant alpha 2-interferon].
_h[electronic resource]
260 _bVestnik Rossiiskoi akademii meditsinskikh nauk
_c1993
300 _a29-31 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aCytopathogenic Effect, Viral
650 0 4 _aDrug Carriers
650 0 4 _aHumans
650 0 4 _aInterferon Type I
_xadministration & dosage
650 0 4 _aInterferon alpha-2
650 0 4 _aInterferon-alpha
650 0 4 _aLiposomes
650 0 4 _aMethods
650 0 4 _aRecombinant Proteins
650 0 4 _aVesicular stomatitis Indiana virus
_xdrug effects
700 1 _aLuk'ianov, A N
700 1 _aNesterov, A E
700 1 _aKolokol'tsov, A A
700 1 _aTorchilin, V P
700 1 _aPopov, V F
700 1 _aVardanian, N V
700 1 _aAntonov, N A
773 0 _tVestnik Rossiiskoi akademii meditsinskikh nauk
_gno. 2
_gp. 29-31
999 _c7688038
_d7688038